Literature DB >> 7790951

FDG-PET in early infancy: simplified quantification methods to measure cerebral glucose utilization.

H Suhonen-Polvi1, U Ruotsalainen, A Kinnala, J Bergman, M Haaparanta, M Teräs, P M akel a, O Solin, U Wegelius.   

Abstract

UNLABELLED: For further insight into the physiology and pathogenesis of the developing brain, quantification of the cerebral glucose metabolism is needed. Arterial blood sampling or sampling of great volumes of blood is not justified for the purpose of PET studies in children. Therefore, we have developed simplified PET approaches to analyze brain FDG examinations during infancy.
METHODS: The study consisted of 18 FDG-PET examinations chosen from our research protocols concerning hypoxicischemic encephalopathy and severe neonatal hypoglycemia. The input function for graphical analysis according to Patlak was derived in two ways: (1) a combined time-activity curve derived from the left ventricular activity concentration (first 7-17 min of the study) and radioactivity concentration in venous whole-blood samples and; (2) activity concentration measured in whole-blood venous blood samples (arterial plasma in one case). As an alternative for semiquantitation, the standardized uptake values (SUV) were calculated and correlated to local cerebral metabolic rates for glucose (LCMRGlc).
RESULTS: The influx rate constants (Ki) and LCMRGlc values obtained using the combined curve versus venous curve did not differ statistically (p > 0.05). There was a good correlation between the SUV and LCMRGlc values (r = 0.83, p < 0.001).
CONCLUSION: Local cerebral metabolic rates for glucose can be accurately calculated by using the combined curve (left ventricular activity concentration during first 5 min of the study and 2-3 venous whole-blood samples at the end of the study) for even the smallest pediatric patients. When blood samples cannot be obtained, SUV values provide an alternative for estimation of the cerebral glucose uptake and interindividual comparison of the patients.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7790951

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  16 in total

1.  Has PET become an important clinical tool in paediatric imaging?

Authors:  Klaus Hahn; Thomas Pfluger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02-05       Impact factor: 9.236

2.  Cerebral metabolic rate for glucose during the first six months of life: an FDG positron emission tomography study.

Authors:  A Kinnala; H Suhonen-Polvi; T Aärimaa; P Kero; H Korvenranta; U Ruotsalainen; J Bergman; M Haaparanta; O Solin; P Nuutila; U Wegelius
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-05       Impact factor: 5.747

3.  Differential kinetics of α-[¹¹C]methyl-L-tryptophan on PET in low-grade brain tumors.

Authors:  Csaba Juhász; Otto Muzik; Diane C Chugani; Harry T Chugani; Sandeep Sood; Pulak K Chakraborty; Geoffrey R Barger; Sandeep Mittal
Journal:  J Neurooncol       Date:  2010-07-30       Impact factor: 4.130

4.  Tryptophan metabolism in breast cancers: molecular imaging and immunohistochemistry studies.

Authors:  Csaba Juhász; Zeina Nahleh; Ian Zitron; Diane C Chugani; Majid Z Janabi; Sudeshna Bandyopadhyay; Rouba Ali-Fehmi; Thomas J Mangner; Pulak K Chakraborty; Sandeep Mittal; Otto Muzik
Journal:  Nucl Med Biol       Date:  2012-03-22       Impact factor: 2.408

5.  Increased tryptophan uptake on PET has strong independent prognostic value in patients with a previously treated high-grade glioma.

Authors:  David O Kamson; Sandeep Mittal; Natasha L Robinette; Otto Muzik; William J Kupsky; Geoffrey R Barger; Csaba Juhász
Journal:  Neuro Oncol       Date:  2014-03-26       Impact factor: 12.300

6.  Evolution of cortical metabolic abnormalities and their clinical correlates in Sturge-Weber syndrome.

Authors:  C Juhasz; C E A Batista; D C Chugani; O Muzik; H T Chugani
Journal:  Eur J Paediatr Neurol       Date:  2007-04-03       Impact factor: 3.140

7.  Reduced uptake of 18F-FDG and 15O-H2O in Alzheimer's disease-related regions after glucose loading.

Authors:  Kenji Ishibashi; Keiichi Kawasaki; Kiichi Ishiwata; Kenji Ishii
Journal:  J Cereb Blood Flow Metab       Date:  2015-06-10       Impact factor: 6.200

8.  Quantification of tryptophan transport and metabolism in lung tumors using PET.

Authors:  Csaba Juhász; Otto Muzik; Xin Lu; M Salik Jahania; Ayman O Soubani; Majid Khalaf; Fangyu Peng; Thomas J Mangner; Pulak K Chakraborty; Diane C Chugani
Journal:  J Nucl Med       Date:  2009-02-17       Impact factor: 10.057

9.  Cerebral glucose metabolism on positron emission tomography of children.

Authors:  Zuyao Y Shan; Andrew J Leiker; Arzu Onar-Thomas; Yimei Li; Tianshu Feng; Wilburn E Reddick; David C Reutens; Barry L Shulkin
Journal:  Hum Brain Mapp       Date:  2013-07-29       Impact factor: 5.038

10.  Imaging correlates of differential expression of indoleamine 2,3-dioxygenase in human brain tumors.

Authors:  Carlos E A Batista; Csaba Juhász; Otto Muzik; William J Kupsky; Geoffrey Barger; Harry T Chugani; Sandeep Mittal; Sandeep Sood; Pulak K Chakraborty; Diane C Chugani
Journal:  Mol Imaging Biol       Date:  2009-05-12       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.